PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426V956. A total of 1 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 5 | -16.7% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 6 | -70.0% | 0.00% | – |
| Q3 2018 | $1,000 | -66.7% | 20 | +42.9% | 0.00% | – |
| Q2 2018 | $3,000 | – | 14 | +1300.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 1 | -66.7% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 3 | -70.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 10 | +900.0% | 0.00% | – |
| Q1 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |